Home > Healthcare > Pharmaceuticals > Pharma Exicipients > Pharmaceutical Gelatin Market

Pharmaceutical Gelatin Market Trends

Report ID: GMI5710
Published Date: May 2023
Report Format: PDF

Download Free Sample

Pharmaceutical Gelatin Market Trends

The increasing initiatives from major market participants to develop revolutionary gelatin capsule shells using innovative technologies is opening up multiple opportunities for market progress. For example, etectRx, Inc., a digital health startup, has begun research to assess antiretroviral drug adherence among prescription opioid users infected with the human immunodeficiency virus (HIV). The ID-Cap System consists of a hard gelatin capsule with an embedded ingestible wireless sensor and a wearable reader will be used in the "MyTPill" experiment to monitor patient adherence. Such initiatives by market players is projected to expand the usage of gelatin in the production of hard gelatin capsules (ID-Cap), thereby enhancing the market revenue.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Pharmaceutical gelatin market size was USD 1.1 billion in 2022 and will reach USD 1.9 billion by the end of 2032.

Pharmaceutical gelatin industry share from the Type B category was 65.4% in the year 2022 and will expand further due to factors including cost-effective production due to the availability of raw materials and its use in a variety of applications across the pharmaceutical sector.

North America pharmaceutical gelatin market share was 41.2% in 2022 owing to the presence of key market participants along with developed healthcare infrastructure.

NITTA GELATIN, INC., GELITA AG, Tessenderlo Group (PB Leiner), Weishardt, Trobas Gelatine B.V., Lonza, India Gelatine & Chemicals Ltd, Gelnex, Juncà Gelatines SL and ITALGEL S.p.A.